Postpandemic Physician Revenue Recovery Varies by Specialty, Practice Type
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, July 5, 2024 -- Pandemic-associated physician revenue recovery in 2021 and 2022 varied by specialty and practice type, according to a study published in the July issue of Health Affairs.
Ravi B. Parikh, M.D., from the University of Pennsylvania in Philadelphia, and colleagues assessed pandemic-related impact on physician revenue (2020 to 2022) and how revenue varied by physician specialty and practice setting. The analysis included linked medical claims from a large national federation of commercial health plans to physician and practice data.
The researchers found that surgical specialties, emergency medicine, and medical subspecialties each experienced more than a 9 percent adjusted gross revenue decline in 2020 compared with prepandemic baselines. Pathology and psychiatry revenue experienced robust recovery by 2022, while surgical and oncology revenue remained at or below baseline. For physicians practicing in hospital-owned practices and in practices participating in accountable care organizations, revenue recovery in 2022 was greater.
"Given that financial constraints among physicians have been associated with health care consolidation and with leaving practice, policy makers may consider closer monitoring of revenue trends among physicians, particularly in those specialties with sustained gross revenue reductions during the pandemic," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-06 01:15
Read more
- Thyroid Problems
- Tired of Tossing and Turning? Try These 11 Products for Insomnia
- FDA Approves Nemluvio for Prurigo Nodularis
- Common Cold Symptoms
- Discipline for Teens
- The Problem with Modern Sex Education — and Where We Go from Here
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions